Canthaxanthin sales will grow through 2036, led by synthetic canthaxanthin at 84% of the nature segment by 2026. The market was valued at USD 135.2 million in 2025 and is expected to reach USD 278.8 million by 2036, with an incremental opportunity of USD 134.4 million between 2026 and 2036.